This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract covers the supply of 90-count tablets of the anticoagulant medication Xarelto (rivaroxaban) 20 mg for a ceiling value of $56,461.53. The contract has a period of performance through December 3, 2024 and utilizes a firm-fixed price pricing structure. This award is not designated as a set-aside contract. The DLA is the primary contracting agency, supporting medical supply procurement for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA Troop Support Medical to provide a comprehensive range of pharmaceuticals and medical supplies across multiple therapeutic areas.
Generated 3/9/25, 12:49 AM